Catalyst Wire Dossier Catalyst Wire Dossier

BIII 890 CL

· Boehringer Ingelheim
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for BIII 890 CL, covering 2014-10-20 to 2014-10-21. Get the full timeline:

Most recent: Clinical Trial Update: Single Increasing Doses of BIII 890 CL in Healthy Young Male Volunteers and in Healthy Elderly Male and Female Volunteers [Phase 1]

See pricing